Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 17;12(12):6102-12.
doi: 10.3390/md12126102.

Anti-mycobacterial nucleoside antibiotics from a marine-derived Streptomyces sp. TPU1236A

Affiliations

Anti-mycobacterial nucleoside antibiotics from a marine-derived Streptomyces sp. TPU1236A

Ying-Yue Bu et al. Mar Drugs. .

Abstract

Five new nucleoside antibiotics, named streptcytosines A-E (1-5), and six known compounds, de-amosaminyl-cytosamine (6), plicacetin (7), bamicetin (8), amicetin (9), collismycin B (10), and SF2738 C (11), were isolated from a culture broth of Streptomyces sp. TPU1236A collected in Okinawa, Japan. The structures of new compounds were elucidated on the basis of their spectroscopic data (HRFABMS, IR, UV, and 2D NMR experiments including 1H-1H COSY, HMQC, HMBC, and NOESY spectra). Streptcytosine A (1) belonged to the amicetin group antibiotics, and streptcytosines B-E (2-5) were derivatives of de-amosaminyl-cytosamine (6), 2,3,6-trideoxyglucopyranosyl cytosine. Compound 1 inhibited the growth of Mycobacterium smegmatis (MIC = 32 µg/mL), while compounds 2-5 were not active at 50 µg/disc. Bamicetin (8) and amicetin (9) showed the MICs of 16 and 8 µg/mL, respectively.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of new compounds 15 isolated from Streptomyces sp. TPU1236A.
Figure 2
Figure 2
Structures of known compounds 611 isolated from Streptomyces sp. TPU1236A.
Figure 3
Figure 3
1H-1H COSY and key HMBC correlations for compound 1.
Figure 4
Figure 4
1H-1H COSY and key HMBC correlations for compounds 25.

References

    1. Zumla A., Raviglione M., Hafner R., von Reyn C.F. Tuberculosis. N. Engl. J. Med. 2013;368:745–755. doi: 10.1056/NEJMra1200894. - DOI - PubMed
    1. Riccardi G., Pasca M.R. Trends in discovery of new drugs for tuberculosis therapy. J. Antibiot. 2014;67:655–659. doi: 10.1038/ja.2014.109. - DOI - PubMed
    1. Ntie-Kang F., Yong J.N., Owono L.C., Sippl W., Megnassan E. Perspectives on tuberculosis pathogenesis and discovery of anti-tubercular drugs. Curr. Med. Chem. 2014;21:3466–3477. doi: 10.2174/0929867321666140706144933. - DOI - PubMed
    1. World Health Organization (WHO) Global Tuberculosis Report 2013. [(accessed on 12 October 2014)]. Available online: http://www.who.int/tb/publications/global_report/en/
    1. Espinal M.A. The global situation of MDR-TB. Tuberculosis. 2003;83:44–51. - PubMed

Publication types

MeSH terms

LinkOut - more resources